# Rate of Tranexamic Acid Administration on Blood Pressure (RateTXA) Study.

> **NCT06356948** · PHASE4 · RECRUITING · sponsor: **University of British Columbia** · enrollment: 110 (estimated)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** Tranexamic Acid (TXA)

## Key facts

- **NCT ID:** NCT06356948
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-30
- **Primary completion:** 2027-07-30
- **Final completion:** 2027-12-30
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2024-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06356948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06356948, "Rate of Tranexamic Acid Administration on Blood Pressure (RateTXA) Study.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06356948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*